If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
GASTROENTEROLOGY
EMJ Gastroenterol. 2019 Suppl 3 • europeanmedical-journal.com
INSIDE
Defining the Future of Inflammatory
Bowel Disease Care: The Pivotal Role
of Personalised Treatment
Defining the Future of Inflammatory Bowel Disease
Care: The Pivotal Role of Personalised Treatment
This symposium took place on 8th March 2019 as part of the 14th
European Crohn’s and Colitis Organisation (ECCO) Congress in
Copenhagen, Denmark
Speakers: Peter Irving,1 Marieke Pierik,2 Jonas Halfvarson,3 Frank Behrens,4
Claudio Fiocchi5
1. Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust,
London, UK
2. Maastricht UMC+, Maastricht, the Netherlands
3. Department of Gastroenterology, Faculty of Medicine and Health, Örebro
University, Örebro, Sweden
4. Depar
GASTROENTEROLOGY EMJ Gastroenterol. 2019 Suppl 3
Defining the Future of Inflammatory Bowel Disease
Importantly, it is acknowledged that IBD is not c
Table 1: Predictors of disease course in ulcerati
example, when presented with an IBD patient with
provide personalised management now, while we awa
This is also observed in patients with coeliac di
is positive or negative is unknown. It has been s
Using a systems biology approach, integrating inf
Abstract 637. ACR/ARHP Annual Meeting, 3-8 Novemb